SPARC Site 1
Hyderabaad, Andhra Pradesh, India
NCT Number: NCT00862355
Bioequivalence study of SPARC147609
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Phase 1
Hyderabaad, Andhra Pradesh, India
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
IV infusion
IV infusion
Time frame: 2 cycles
Time frame: 2 cycles
Sun Pharma Advanced Research Company Limited
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01519869
Adnexal Diseases, Carcinoma
Lexington, Kentucky, United States
View Trial DetailsNCT06827353
Adnexal Diseases, Carcinoma
Nîmes, Occitanie, France
View Trial DetailsNCT03180294
Adnexal Diseases, Breast Carcinoma
Anaheim, California, United States
View Trial DetailsNCT05494580
Adnexal Diseases, Endocrine Gland Neoplasms
Guangzhou, China
View Trial Details